MC

466.3

-0.21%↓

SANES

9.491

-0.44%↓

SAF

283.6

-1.15%↓

BBVA

18.275

+0.11%↑

BNP

83.22

+0.58%↑

MC

466.3

-0.21%↓

SANES

9.491

-0.44%↓

SAF

283.6

-1.15%↓

BBVA

18.275

+0.11%↑

BNP

83.22

+0.58%↑

MC

466.3

-0.21%↓

SANES

9.491

-0.44%↓

SAF

283.6

-1.15%↓

BBVA

18.275

+0.11%↑

BNP

83.22

+0.58%↑

MC

466.3

-0.21%↓

SANES

9.491

-0.44%↓

SAF

283.6

-1.15%↓

BBVA

18.275

+0.11%↑

BNP

83.22

+0.58%↑

MC

466.3

-0.21%↓

SANES

9.491

-0.44%↓

SAF

283.6

-1.15%↓

BBVA

18.275

+0.11%↑

BNP

83.22

+0.58%↑

Search

Elecnor SA

Open

SectorFinanciën

31.2 8.52

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

28.8

Max

31.35

Belangrijke statistieken

By Trading Economics

Inkomsten

18M

61M

Verkoop

461M

2.4B

K/W

Sectorgemiddelde

22.443

54.048

Winstmarge

2.539

Werknemers

28,218

EBITDA

92M

146M

Dividenden

By Dow Jones

Volgende Winsten

28 apr 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

43M

2.5B

Vorige openingsprijs

22.68

Vorige sluitingsprijs

31.2

Nieuwssentiment

By Acuity

35%

65%

95 / 441 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Elecnor SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 mrt 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mrt 2026, 22:55 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mrt 2026, 21:51 UTC

Acquisities, Fusies, Overnames

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mrt 2026, 23:59 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 mrt 2026, 23:59 UTC

Marktinformatie

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mrt 2026, 23:50 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mrt 2026, 23:37 UTC

Marktinformatie

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

23 mrt 2026, 22:42 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mrt 2026, 22:40 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mrt 2026, 22:23 UTC

Marktinformatie

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mrt 2026, 22:22 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mrt 2026, 22:21 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mrt 2026, 22:20 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mrt 2026, 22:19 UTC

Acquisities, Fusies, Overnames

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mrt 2026, 22:18 UTC

Acquisities, Fusies, Overnames

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mrt 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mrt 2026, 22:08 UTC

Marktinformatie

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 mrt 2026, 21:42 UTC

Marktinformatie

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mrt 2026, 21:32 UTC

Winsten

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mrt 2026, 21:10 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mrt 2026, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 mrt 2026, 20:50 UTC

Marktinformatie
Winsten
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Elecnor SA Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technische score

By Trading Central

18.36 / 20.25Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Very Strong Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

95 / 441 Rangschikking in Financiën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Elecnor SA

Elecnor, S.A. engages in the development, construction, and operation of projects and services in Spain and internationally. The company operates energy transports, conversion, and distribution; generates power from wind farms, as well as solar, combined cycle, biomass, and hydroelectric plants; and provides gas related services covering transmission of power generated by gas-fired plants, construction and maintenance of distribution pipelines, and comprehensive services, as well as compression, metering, and regulator stations. It also offers telecommunications infrastructure, systems and networks, automation and infrastructure control, smart cities, and industrial automation; catenary, substations, signalling and interlocks, communications, and remote control and control; and technical assistance, administrative support, network operations, live working, installation and equipment maintenance, and customer management services. In addition, the company provides electricity, HVAC, fire protection, ventilation, energy efficiency, automation and control, management systems, safety and security, public address and sound systems, telecommunications, and plumbing and sewer systems; site and building rehabilitation, installations, outfitting and equipment, ornamental lighting, and prefabs; Water resource planning and transport and distribution networks; environmental development and protection policies; and treatment and reuse of waste and sewerage and water purification services. Further, it involved in space services for energy and environment, aerospace, aeronautics and defence, transport, safety and security, building, industry, and telecommunications sectors. Elecnor, S.A. was incorporated in 1958 and is based in Madrid, Spain. Elecnor, S.A. is a subsidiary of Cantiles XXI, S.L.
help-icon Live chat